12-Week Study in Adult Subjects With Asthma
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 600
Summary
- Conditions
- Asthma
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 60 years
- Gender
- Both males and females
Description
The primary outcome measure is FEV1 (Forced Expiry Volume in 1 second) and the secondary outcome measure is Peak Expiratory Flow Rate (PEFR), Asthma Control Questionnaire (ACQ), nighttime awakenings and reduce medication usage.
The primary outcome measure is FEV1 (Forced Expiry Volume in 1 second) and the secondary outcome measure is Peak Expiratory Flow Rate (PEFR), Asthma Control Questionnaire (ACQ), nighttime awakenings and reduce medication usage.
Tracking Information
- NCT #
- NCT01516073
- Collaborators
- Not Provided
- Investigators
- Study Director: Imtiaz Chaudry Dey Pharma, L.P.
Get Well Soon